These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 29332262)

  • 21. Sporadic malignant peripheral nerve sheath tumour (MPNST) in a 3-year-old girl: A diagnostic challenge.
    Zawawi MSF; Wan Ismail WFN; Mustapar N; Mohamad N; Nasir A; Tuan Sharif SE
    Malays J Pathol; 2022 Apr; 44(1):115-120. PubMed ID: 35484894
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of p53 as a strong predictor of survival for patients with malignant peripheral nerve sheath tumors.
    Brekke HR; Kolberg M; Skotheim RI; Hall KS; Bjerkehagen B; Risberg B; Domanski HA; Mandahl N; Liestøl K; Smeland S; Danielsen HE; Mertens F; Lothe RA
    Neuro Oncol; 2009 Oct; 11(5):514-28. PubMed ID: 19182148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of insulin-like growth-factor-1 receptor (IGF-1R) in peripheral nerve sheath tumors in neurofibromatosis type 1.
    Friedrich RE; Keiner D; Hagel C
    Anticancer Res; 2007; 27(4A):2085-90. PubMed ID: 17649826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regular expression of osteopontin in granular cell tumor: distinctive feature among Schwannian cell tumors.
    Hoshi N; Sugino T; Suzuki T
    Pathol Int; 2005 Aug; 55(8):484-90. PubMed ID: 15998376
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical evaluation of H3K27 trimethylation in malignant peripheral nerve sheath tumors.
    Otsuka H; Kohashi K; Yoshimoto M; Ishihara S; Toda Y; Yamada Y; Yamamoto H; Nakashima Y; Oda Y
    Pathol Res Pract; 2018 Mar; 214(3):417-425. PubMed ID: 29482987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical signs of neurofibromatosis impact on the outcome of malignant peripheral nerve sheath tumors.
    Lamm W; Schur S; Köstler WJ; Funovics P; Windhager R; Amann G; Panotopoulos J; Pokrajac B; Brodowicz T
    Oncology; 2014; 86(2):122-6. PubMed ID: 24480823
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Expression of osteopontin and survivin in prostate cancer and the clinical significance].
    Yu HB; Han XB; Liang YQ; Liu JG; Wang H
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 May; 30(5):1141-3. PubMed ID: 20501415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plexiform neurofibroma with and without associated malignant peripheral nerve sheath tumor: a clinicopathologic and immunohistochemical analysis of 54 cases.
    McCarron KF; Goldblum JR
    Mod Pathol; 1998 Jul; 11(7):612-7. PubMed ID: 9688181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metastatic Malignant Peripheral Nerve Sheath Tumor With NF1 Successfully Treated With 'Gradual Subtraction' ICE Chemotherapy.
    Wang Y; Katagiri H; Murata H; Wasa J; Miyagi M; Kakuda Y; Takahashi M
    Anticancer Res; 2020 Mar; 40(3):1619-1624. PubMed ID: 32132065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methylation-based classification of benign and malignant peripheral nerve sheath tumors.
    Röhrich M; Koelsche C; Schrimpf D; Capper D; Sahm F; Kratz A; Reuss J; Hovestadt V; Jones DT; Bewerunge-Hudler M; Becker A; Weis J; Mawrin C; Mittelbronn M; Perry A; Mautner VF; Mechtersheimer G; Hartmann C; Okuducu AF; Arp M; Seiz-Rosenhagen M; Hänggi D; Heim S; Paulus W; Schittenhelm J; Ahmadi R; Herold-Mende C; Unterberg A; Pfister SM; von Deimling A; Reuss DE
    Acta Neuropathol; 2016 Jun; 131(6):877-87. PubMed ID: 26857854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Malignant peripheral nerve sheath tumors of the spine: results of surgical management from a multicenter study.
    Chou D; Bilsky MH; Luzzati A; Fisher CG; Gokaslan ZL; Rhines LD; Dekutoski MB; Fehlings MG; Ghag R; Varga P; Boriani S; Germscheid NM; Reynolds JJ;
    J Neurosurg Spine; 2017 Mar; 26(3):291-298. PubMed ID: 27834629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Osteopontin: its potential role in cancer of children and young adults.
    Karpinsky G; Fatyga A; Krawczyk MA; Chamera M; Sande N; Szmyd D; Izycka-Swieszewska E; Bien E
    Biomark Med; 2017 Apr; 11(4):389-402. PubMed ID: 28326824
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased expression of survivin in hepatoblastoma after chemotherapy.
    Uehara S; Oue T; Kawatsu M; Nara K; Fukuzawa M
    Eur J Pediatr Surg; 2013 Oct; 23(5):400-4. PubMed ID: 23444076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vascular endothelial growth factor, basic fibroblast growth factor and epithelial growth factor receptor in peripheral nerve sheath tumors of neurofibromatosis type 1.
    Friedrich RE; Beer C; Glatzel M; Hagel C
    Anticancer Res; 2015 Jan; 35(1):137-44. PubMed ID: 25550544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic stratification of stage IIIA pN2 non-small cell lung cancer by hierarchical clustering analysis of tissue microarray immunostaining data: an Alpe Adria Thoracic Oncology Multidisciplinary Group study (ATOM 014).
    Grossi F; Spizzo R; Bordo D; Cacitti V; Valent F; Rossetto C; Follador A; Di Terlizzi S; Aita M; Morelli A; Fasola G; Consiglieri C; Ceschia T; Beltrami CA; Belvedere O
    J Thorac Oncol; 2010 Sep; 5(9):1354-60. PubMed ID: 20631638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survivin and cycline D1 expressions are associated with malignant potential in mucinous ovarian neoplasms.
    Kanter M; Turan G; Usta C; Usta A; Esen HH; Tavlı L; Celik C; Demirkol Y; Kanter B
    J Mol Histol; 2016 Apr; 47(2):145-52. PubMed ID: 26815661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1: a clinicopathologic and molecular study of 17 patients.
    Leroy K; Dumas V; Martin-Garcia N; Falzone MC; Voisin MC; Wechsler J; Revuz J; Créange A; Levy E; Lantieri L; Zeller J; Wolkenstein P
    Arch Dermatol; 2001 Jul; 137(7):908-13. PubMed ID: 11453810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathologic Response to Neoadjuvant Therapy is Associated With Improved Long-term Survival in High-risk Primary Localized Malignant Peripheral Nerve Sheath Tumors.
    Shurell-Linehan E; DiPardo BJ; Elliott IA; Graham DS; Eckardt MA; Dry SM; Nelson SD; Singh AS; Kalbasi A; Federman N; Bernthal NM; Eilber FC
    Am J Clin Oncol; 2019 May; 42(5):426-431. PubMed ID: 30913092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance of AKT/mTOR and MAPK pathways and antitumor effect of mTOR inhibitor in NF1-related and sporadic malignant peripheral nerve sheath tumors.
    Endo M; Yamamoto H; Setsu N; Kohashi K; Takahashi Y; Ishii T; Iida K; Matsumoto Y; Hakozaki M; Aoki M; Iwasaki H; Dobashi Y; Nishiyama K; Iwamoto Y; Oda Y
    Clin Cancer Res; 2013 Jan; 19(2):450-61. PubMed ID: 23209032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of cyclin D1 and survivin expression with sensitivity to radiotherapy in patients with nasopharyngeal carcinoma.
    Fu SM; Xu MX; Lin SM; Liang Z; Cai JH
    Genet Mol Res; 2014 Feb; 13(2):3502-9. PubMed ID: 24615109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.